MedDataX Logo

Assessing Choice in the Employer Setting (ACES) Study

NCT00808808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4411

Last updated 2013-11-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

Conditions

  • Healthy

Interventions

BIOLOGICAL

Choice of TIV or FluMist with baseline advertisement

An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist

OTHER

Choice of TIV or FluMist with enhanced advertisement and incentives

An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination

BIOLOGICAL

Control - Usual care offering TIV only with baseline advertisement

A control arm of usual care offering TIV with baseline advertisement

Sponsors & Collaborators

  • Passport Health

    collaborator INDUSTRY

  • University of Pittsburgh

    collaborator OTHER

  • MedImmune LLC

    lead INDUSTRY

Principal Investigators

  • Seth Toback, M.D. · MedImmune LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2008-11-30
Completion
2008-12-31

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00808808 on ClinicalTrials.gov